Pharmac consultation on proposal to amend the Special Authority access criteria for type 2 diabetes medicines
Our Co-Chair Glen Tupuhi has sent a submission on behalf of Te Tiratū Iwi Māori Partnership Board opposing Pharmac’s proposal to remove ethnic equity criteria for type 2 diabetes medicines (SGLT2 inhibitors and GLP-1 receptor agonists). The consultation closes 11 June 2026.
Medical Council of NZ submission on cultural competence & cultural safety
Our Board member, clinician and Senior Lecturer in Medical Education at the University of Auckland, Dr Mataroria Lyndon has responded to new draft guidance from the Medical Council of New Zealand on cultural competence, cultural safety, and hauora Māori.